Cromos™ Pharma’s CEO, Dr. Vlad Bogin, will attend the 37th Annual J.P. Morgan Healthcare Conference which will take place 7-10 January 2018 in San Francisco, CA, USA.
The J.P. Morgan Healthcare Conference continues its tradition of hosting the largest and most informative healthcare investment symposium in the industry. In 2019, more than 400 companies, both public and private, are expected to deliver presentations to more than 8,000 attendees. The conference provides a unique opportunity for investors to visit with so many inter-related industry leaders in one setting.
Cromos Pharma is a contract research organization (CRO) with strong presence in Central/Post-Soviet Europe and in the United States. Established in 2004, Cromos Pharma is a full service CRO that has vast expertise in running global generics and biosimilar studies. By including patients from Eastern Europe and the former Soviet bloc we offer rapid study initiation, highest subject recruitment and retention rates, lowest drop-out rates and high quality of clinical data. Our motivated study investigators are eager to participate in clinical trials and our company employs some of the most experienced staff, most of whom have doctor’s degrees.
If you are in San Francisco on these dates, Dr. Bogin looks forward to meeting you and discussing how Cromos Pharma can support your clinical trials from a strategic early phase study design to the final report. Please contact Dr. Bogin directly to arrange a meeting or an informal chat over a coffee.
Cromos Pharma is looking forward to taking part in the upcoming DIA Europe conference (15 – 19 March 2021). A highly collaborative event, it’s a great chance to meet with future partners and hear from innovators across the entire life sciences spectrum.
Cromos Pharma is delighted to be participating in MAGI’s Clinical Research vConference (2-5 & 9-12 November). Our CEO Vlad Bogin, MD, FACP will be giving a presentation on the timely topic of Crisis Management (2 November, 2:30 PM-3:30 PM).